Serum Autotaxin/ENPP2 correlates with insulin resistance in older humans with obesity

Serum autotaxin is independently associated with hepatic steatosis in women with severe obesity

(2015) Vikrant P. Rachakonda et al.   Obesity

ENPP2 Contributes to Adipose Tissue Expansion and Insulin Resistance in Diet-Induced Obesity

(2014) S. Nishimura et al.   DIABETES

Obesity and Its Metabolic Complications: The Role of Adipokines and the Relationship between Obesity, Inflammation, Insulin Resistance, Dyslipidemia and Nonalcoholic Fatty Liver Disease

(2014) Un Jung et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

LPA receptor signaling: pharmacology, physiology, and pathophysiology

(2014) Yun C. Yung et al.   JOURNAL OF LIPID RESEARCH

Towards selective lysophospholipid GPCR modulators

(2014) Julia K. Archbold et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

Involvement of autotaxin/lysophosphatidic acid signaling in obesity and impaired glucose homeostasis

(2013) Chloé Rancoule et al.   BIOCHIMIE

Lysophosphatidic acid impairs glucose homeostasis and inhibits insulin secretion in high-fat diet obese mice

(2013) C. Rancoule et al.   DIABETOLOGIA

Prevalence of Obesity and Trends in the Distribution of Body Mass Index Among US Adults, 1999-2010

(2012) Katherine M. Flegal et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Depot-specific regulation of autotaxin with obesity in human adipose tissue

(2012) Chloé Rancoule et al.   JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY

Autotaxin and Its Product Lysophosphatidic Acid Suppress Brown Adipose Differentiation and Promote Diet-Induced Obesity in Mice

(2012) Lorenzo Federico et al.   MOLECULAR ENDOCRINOLOGY

Specific increase in serum autotaxin activity in patients with pancreatic cancer

(2011) Yousuke Nakai et al.   CLINICAL BIOCHEMISTRY

Effects of weight loss and exercise on insulin resistance, and intramyocellular triacylglycerol, diacylglycerol and ceramide

(2011) J. J. Dubé et al.   DIABETOLOGIA

Adipose-specific disruption of autotaxin enhances nutritional fattening and reduces plasma lysophosphatidic acid

(2011) Rodolphe Dusaulcy et al.   JOURNAL OF LIPID RESEARCH

LPA Receptors: Subtypes and Biological Actions

(2010) Ji Woong Choi et al.   Annual Review of Pharmacology and Toxicology

Aiming drug discovery at lysophosphatidic acid targets

(2010) Gabor Tigyi   BRITISH JOURNAL OF PHARMACOLOGY

Autotaxin--an LPA producing enzyme with diverse functions

(2010) K. Nakanaga et al.   JOURNAL OF BIOCHEMISTRY

Rapid clearance of the circulating metastatic factor autotaxin by the scavenger receptors of liver sinusoidal endothelial cells

(2009) Silvia Jansen et al.   CANCER LETTERS

Autotaxin

(2009) Jean A. Boutin et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome

(2009) E. Maury et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

Lysophosphatidic acid (LPA) receptors: Signaling properties and disease relevance

(2009) Mu-En Lin et al.   PROSTAGLANDINS & OTHER LIPID MEDIATORS

Exercise-induced alterations in intramyocellular lipids and insulin resistance: the athlete's paradox revisited

(2008) John J. Dubé et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

Autotaxin (ATX): A multi-functional and multi-modular protein possessing enzymatic lysoPLD activity and matricellular properties

(2008) L YUELLING   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS

The Metabolic Syndrome

(2008) Marc-Andre Cornier et al.   ENDOCRINE REVIEWS

Validation of an autotaxin enzyme immunoassay in human serum samples and its application to hypoalbuminemia differentiation

(2007) Kazuhiro Nakamura et al.   CLINICA CHIMICA ACTA